In our practice we spend time in the community and encounter patients who are seeing primary care physicians and are on minimal therapy as well as patients from our clinic who are managed more aggressively….

Gregory Peterson and Craig Spellman are two physicians who see a lot of diabetes patients in their practices, and are very familiar with the use of GLP-1 agonists. Both of them have written journal articles about the use of these newer medications….

Most of my colleagues wait till their patients are maxed out on oral medications — often this means that they are on 3 or 4 medications without achieving control, before starting them on either basal insulin or GLP-1 analogs….

Patient Education and Monitoring Recommendations for the Use of GLP-1’s Unlike most diseases, diabetes requires extensive patient self-management….

I am often in a position to recommend the selection of medications for the patients with type 2 diabetes who I see in prescribers’ offices.   Most medical practitioners will make metformin their first choice as this has become the standard of care and is a very effective and inexpensive …

Is it intensity or duration that gives the best results when you exercise? This week’s Clinical Text helps us to maximize both for our patients and what the differences are when you have diabetes. Our Disaster Averted gets serious about the problems that can happen when newer, younger physicians don’t …

2.7 Evaluation of the Intensity and Duration of the Effort The following is an excerpt that answers the questions regarding the evaluation of the intensity and duration of the effect of exercise.   Intensity Effort intensity is well correlated with heart rate (HR) in the absence of heart rhythm abnormalities …

  Our Homerun Slides set this week, A Teaching Resource Guide, Part 1 of 2, is geared toward patient education and comes courtesy of Novo Nordisk. The program covers medications, hypoglycemia, nutrition, physical activity, monitoring and much more….

I was at a program last week and we were talking about testosterone replacement in men and how our patients often go for years with low levels. There was a lot of conversation about testing and why it does not get done and one of the prescribers in attendance shared …

FDA Panel Gives Nod to New Diet Drug An FDA advisory committee has voted 18-4, with one abstention, in favor of approving lorcaserin hydrochloride (Lorqess). It would be the first new weight loss drug in more than a decade.